📺 Verpassen Sie nicht unser nächstes #Webinar, das gemeinsam mit BODYMED GmbH am 25. September um 19 Uhr veranstaltet wird: Gesund ist und bleibt man nur mit einer gesunden Leber mit Dr. Hardy Walle, Dr. Med. Nikolaus Scheper und Andrey Popovich. Sie werden die Zusammenhänge zwischen Stoffwechselerkrankungen und Lebererkrankungen erläutern: Ursachen von Fettleber und Leberfibrose. Sie werden auch die verfügbaren Diagnoseinstrumente wie #FibroScan vorstellen, um schließlich ihre Erfahrungen über den Alltag in einer auf #Diabetologie spezialisierten Praxis zu teilen. 📍 Schließen Sie sich uns an : https://lnkd.in/eiuvYWg5 #LiverHealthMatters
Echosens
Équipements médicaux
Paris, Île-de-France 17 020 abonnés
Nous façonnons le futur de la santé du foie. Because liver health matters
À propos
Pionnier dans son domaine, Echosens a modifié considérablement la pratique du diagnostic des maladies du foie avec FibroScan®, la solution non invasive de référence pour une prise en charge globale de la santé du foie. FibroScan® est reconnu dans le monde entier comme l’outil de référence pour l'évaluation de la fibrose et de la stéatose hépatiques avec plus de 4 200 publications soumises à des comités de lecture et plus de 180 recommandations internationales. Echosens distribue FibroScan® dans plus de 100 pays, permettant ainsi la réalisation de millions d'examens du foie dans le monde entier.
- Site web
-
http://www.echosens.com
Lien externe pour Echosens
- Secteur
- Équipements médicaux
- Taille de l’entreprise
- 201-500 employés
- Siège social
- Paris, Île-de-France
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2001
- Domaines
- Diagnostic non-invasif en hépatologie, Pionnier en Elastographie quantitative et Evaluation de la fibrose hépatique et de la cirrhose
Lieux
Employés chez Echosens
Nouvelles
-
🎙️ Don’t miss our latest podcast episode of Liver Health Shaper! Join two of the leading voices in liver health, Dr. Naim Alkhouri, MD, FAASLD, Chief Medical Officer at Arizona Liver Health , and Dr. Mazen Noureddin, MD, MHSc, Professor of Medicine and Director of the Houston Research Institute , as they discuss: 🔸The historic new treatment for MASH – Rezdiffra™ – and what it means for patients 🔸Navigating prior authorization for Rezdiffra™ 🔸The impact of FibroScan® with Guided VCTE™ technology and the new Liver Health Management platform 🎧 Listen here 👉 https://lnkd.in/eWQE7S7u #LiverHealthMatters #MASH #FibroScan #Rezdiffra
-
🌟 Calling all liver health superstars! 🌟 Nominations are now open for the first-ever Super Shaper Award! This is your chance to shine a spotlight on those making a significant impact in liver health. Know a deserving individual? Nominate them today and let’s celebrate the leaders and pioneers advancing liver health ➡️ https://lnkd.in/gqqpbGBE
-
EASD 2024 Congress begins tomorrow in Madrid, Spain: come and meet the Echosens team at the booth N°B10 - Hall 10! We are excited to share the latest medical updates and introducing you to Next Generation FibroScan at the booth! #EASD2024 #FibroScan #LiverHealthMatters European Association for the Study of Diabetes e.V. (EASD)
-
📺 Save the date for our upcoming #webinar spotlighting the newly released Guided VCTE™ technology. Hear from key leaders in liver health Dr. Raj Vuppalanchi and Louise Campbell MSc (AP), RMN, RN, FRCP detail their experience using the next-generation #FibroScan. How Guided VCTE™ Can Optimize Operator & Physician Experience Through Standardization & Increased Efficiency 📍 Find out on September 24 : https://lnkd.in/e2sq83Fd #LiverHealthMatters
-
Come visit us from tomorrow at our booth N°4 at Paris MASH Meeting 2024, organized by Arun Sanyal and Lawrence Serfaty at Institut Pasteur in Paris. Our team is excited to present the #FibroScan® solution and share the latest product innovations for this 10th edition! #Liverhealthmatters #MASH
-
The ALEH 2024 Congress is taking place in Santiago, Chile from September 9-11! We're delighted to be taking part in this year's event and to meet you! We look forward to sharing the latest product innovations and introducing you to FibroScan at the booth #5! #Liverhealthmatters
-
⚡Great news for healthcare providers! As of June 2024, Rezdiffra™ is widely accessible through point-of-care non-invasive testing. 5 things you should know: 👇 1️⃣ Growing coverage: Health plans representing ~120M lives now cover Rezdiffra™. 2️⃣ Non-invasive approval: Most plans accept non-invasive tests (NITs) for Rezdiffra™, eliminating the need for invasive liver biopsies. 3️⃣ #FibroScan® leads the way: FibroScan® stands out as the only point-of-care NIT accepted by all plans that allow NITs for diagnosing F2/F3. 4️⃣ Preferred by major plans: With proprietary biomarkers (LSM by VCTE™, CAP™, and Fast), FibroScan® is the only point-of-care test accepted by major health plans like Blue Cross Blue Shield, Centene, and United Healthcare. 5️⃣ Efficient process: The comprehensive FibroScan® ecosystem, especially myFibroScan, simplifies prior authorization with ready-to-use documentation, saving valuable time. Empower your practice with FibroScan® and help provide your patients access to Rezdiffra™. Learn more here 👉 https://lnkd.in/e-3Ez6BP #LiverHealthMatters #Rezdiffra #MASH
-
📣Introducing the Liver Health Super Shaper award! 📣 The first-ever Liver Health Super Shaper award honors medical professionals for exceptional contributions to enhancing the lives of patients with chronic liver disease. Two deserving winners will receive recognition and an opportunity to donate $10,000 dollars to a health charity of their choice, donated on their behalf from Echosens. Don't miss out on this chance to recognize the unsung heroes in liver health! Nominations are now open – learn more and submit your nomination for a deserving liver hero today ➡️ https://lnkd.in/gqqpbGBE Join us in celebrating and shining a spotlight on our medical professionals helping to change the lives of patients. #FibroScan #LiverHealthMatters
-
Seeking guidance on securing prior authorization for Rezdiffra™? As of June 2024, health plans representing ~120M lives in the U.S. have issued Rezdiffra™ prior authorization criteria. Here’s what you need to know: 👇 #FibroScan #LiverHealthMatters